(R)-4-N-Boc-piperazine-2-carboxylic acid methyl ester, 97.0%, 1g

5-Bromo-[1,1'-biphenyl]-3-amine, 98%, 250mg

2-(Tert-butoxy)propanoic acid, 98%, 2.5g

(2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate, 97%, 5g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

4-Benzyloxy-2-(trifluoromethoxy)phenylboronic acid pinacol ester, 97%, 500mg

N-Benzo[1,3]dioxol-5-yl-2-chloro-acetamide, 97%, 5g

Methyl 3-(3-cyanophenyl)-3-oxopropanoate, 95%, 5g

2-amino-4-(1H-tetrazol-5-yl)benzoic acid, 95.0%, 5g

2-(chloromethyl)-6-(4-chlorophenyl)-1H,4H-thieno[3,2-d]pyrimidin-4-one, 95%, 50mg

2-(3-Chloro-5-ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

tert-Butyl ((1-(hydroxymethyl)cyclobutyl)methyl)carbamate, 95%, 500mg

1-[2-(1H-1,2,4-triazol-1-yl)ethyl]piperazine trihydrochloride hydrate, 95.0%, 10g